-
ADC & High Potency API
From R&D to Commercial Manufacturing — One Stop ServiceChemExpress is one of the earliest CDMO companies engaged in the production of ADC (Antibody Drug Conjugates) & Highly Potent Active Pharmaceutical Ingredients (HPAPIs or HPAIs). We can provide a one-stop CRO & CDMO service for the small molecule part of ADC drugs, as well as customized ADC conjugation services. We are equipped with R&D laboratories, kilogram-scale GMP laboratories and commercial-scale GMP manufacturing workshops for ADC small molecules, which can provide a one-stop service for your project from preclinical to commercialization.
The Shanghai R&D site has 80+ payload (in stock), 400+ linkers (in stock) and 1,000+ experience of linker compound syntheses, which can provide clients with ADC small molecules ranging from milligrams to kilograms. To date, we have empowered our 600+ customers to develop ADC small molecule projects.
ADC Payload-Linker CDMO Integrated Platform
- Preclinical
- Phase I
- Phase II
- Phase III
- Commercial
- Quick Response Fast Delivery
- CMC Services
- Quality by Design：Continuous Optimization and Improvement
- Rich Experience Dedicated & Reliable
- Cost-effective Stable supply
ADC Conjugation Service
- Linker-Payload Screen
- Process Development & Optimization
- Custom Synthesis
Service Type：FFS, FTE, CMC
Capacity
Tofflon separator(OEL＜0.01μg/ m3 ) covering all toxin levels in pharma
SOP Controlled Clean-up: Maximum HPAPI suitability is achieved by negative pressure separators for weighing, process development, handling and pre-lyophilization handling. End-to-end production management in controlled working area.
Kinetic Monitoring: Air dust detection and alarm system, mandatory staff training (SOP for PPE, emergency response).
-
4,400m2GMP KG Scale Plant
-
4,000LTotal volume of the reactor
